data_1c8a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c8a _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.3 t30 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 120.863 0.363 . . . . 5.03 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -88.66 -179.41 6.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.424 -0.798 . . . . 4.3 110.413 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.98 133.64 37.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 2.06 110.449 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -100.24 155.25 17.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 2.24 109.978 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.2 t -79.34 101.25 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.458 -0.776 . . . . 1.62 109.949 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 54' ' ' THR . 15.8 t -116.94 123.48 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.443 -0.786 . . . . 1.6 109.47 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -61.17 132.56 54.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.558 -0.714 . . . . 1.28 109.977 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -82.63 -45.77 14.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 2.98 110.228 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -92.95 179.32 5.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.495 -0.753 . . . . 2.55 110.719 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -90.27 133.56 34.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.636 -0.665 . . . . 2.49 109.597 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.68 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 47.9 mm -110.5 142.36 25.9 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 2.59 110.333 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 42.6 Cg_endo -78.44 -164.71 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.705 1.371 . . . . 2.07 110.358 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.68 144.68 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.18 -0.95 . . . . 3.05 110.601 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 50.09 66.48 1.13 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.367 0.603 . . . . 2.96 110.54 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.452 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 19.8 m -135.34 127.26 29.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.473 -0.767 . . . . 2.03 110.695 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.615 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -70.08 124.99 25.47 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.567 -0.708 . . . . 2.01 109.764 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.97 156.46 39.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.484 -0.76 . . . . 1.51 110.992 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -120.22 178.94 4.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.422 -0.799 . . . . 2.05 110.033 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.97 -42.18 94.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.445 -0.784 . . . . 2.81 110.419 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.11 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.723 . . . . 2.28 110.135 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 55.1 mtt -74.35 -31.81 62.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.549 -0.719 . . . . 2.34 110.57 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 1.4 ttt -86.17 112.49 21.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.381 -0.825 . . . . 3.47 110.509 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -111.42 129.42 56.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.597 -0.689 . . . . 2.64 110.226 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.7 76.7 7.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.461 -0.775 . . . . 1.88 110.139 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -103.55 146.82 27.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.787 . . . . 2.26 110.422 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.3 t -85.39 84.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.502 -0.749 . . . . 2.47 109.449 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 16.2 m -140.55 163.18 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.402 -0.811 . . . . 2.27 110.783 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.49 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 19.9 p -99.53 163.22 18.96 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.599 -0.688 . . . . 3.25 110.269 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -75.83 151.68 95.98 Favored 'Cis proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.91 -2.121 . . . . 2.57 110.835 -0.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.95 89.39 1.41 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.557 0.694 . . . . 3.84 110.593 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 -101.95 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.119 -1.592 . . . . 1.73 109.119 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.438 HG22 HD22 ' A' ' 40' ' ' LEU . 15.6 mt -110.57 131.03 22.28 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.586 -0.949 . . . . 1.86 109.546 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.79 -177.27 2.44 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 124.017 1.535 . . . . 2.05 111.266 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.91 23.71 4.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.496 -0.752 . . . . 2.13 111.321 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -66.95 -50.19 63.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.124 -0.985 . . . . 3.33 109.747 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 2.9 mm-40 -96.01 46.01 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 3.42 109.794 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -53.19 -46.76 97.64 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.594 -0.691 . . . . 2.32 111.322 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.1 Cg_endo -67.96 -28.32 35.68 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.176 1.092 . . . . 2.53 111.237 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 6.1 m-80 -82.47 -42.37 18.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.304 -0.873 . . . . 3.03 110.154 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 HD13 ' HB3' ' A' ' 64' ' ' GLU . 5.5 mp -71.3 -34.46 70.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 3.17 111.232 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.04 144.95 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.336 -0.853 . . . . 2.13 111.04 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.615 ' HA2' ' HB3' ' A' ' 16' ' ' ALA . . . 71.77 13.33 75.11 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.043 -0.823 . . . . 1.62 111.043 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.461 ' CE ' ' HG ' ' A' ' 40' ' ' LEU . 7.4 ptp -74.66 150.92 39.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.912 -1.346 . . . . 3.04 109.514 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.02 130.0 46.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.583 -0.698 . . . . 3.52 110.207 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 m -85.65 159.59 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.64 -0.662 . . . . 1.76 110.374 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.88 -17.66 32.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.742 . . . . 2.63 111.071 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.82 -172.96 4.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.269 -0.895 . . . . 4.31 110.465 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.11 134.13 40.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 2.42 110.216 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 73.4 t -105.93 126.56 30.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.664 . . . . 1.88 109.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.417 ' HA ' HD11 ' A' ' 10' ' ' LEU . 43.0 Cg_endo -71.17 -172.88 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.771 1.406 . . . . 2.08 110.968 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.63 140.31 33.25 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 2.38 111.013 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.82 35.31 79.43 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 110.784 -0.926 . . . . 1.43 110.784 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -88.39 124.86 34.36 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.304 -1.115 . . . . 1.77 110.355 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.0 t -70.47 160.33 32.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.491 -0.756 . . . . 1.76 110.105 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.76 107.56 4.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.407 -0.808 . . . . 1.78 109.906 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.3 mtt -103.31 131.83 21.71 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.536 -0.728 . . . . 3.01 110.319 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.09 -27.68 19.96 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.95 1.5 . . . . 1.58 110.826 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.91 -29.78 63.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.389 -0.819 . . . . 2.84 110.597 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.4 mtt -82.36 -30.78 30.11 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.361 -0.837 . . . . 2.85 110.801 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 78.0 t -101.77 136.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.248 -0.907 . . . . 1.65 110.358 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HE3' ' HG3' ' A' ' 123' ' ' GLN . 14.3 mmtt -71.27 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.444 -0.785 . . . . 4.07 109.515 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.06 85.11 5.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.932 -1.105 . . . . 4.58 109.629 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.64 -40.33 61.56 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.455 -0.778 . . . . 2.23 110.885 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HB3' HD13 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -169.78 -177.22 2.6 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 4.17 110.804 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.45 62.31 7.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 3.94 109.911 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.18 -30.1 65.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.934 -1.266 . . . . 2.46 109.934 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 p -73.79 140.92 46.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 3.0 110.279 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.7 p -90.05 -68.52 0.78 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.56 -0.712 . . . . 4.75 110.354 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -84.92 138.1 37.5 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.456 -0.778 . . . . 3.03 110.139 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 49.1 Cg_endo -73.42 -98.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.811 1.427 . . . . 2.53 110.315 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 -81.86 0.91 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.361 -1.495 . . . . 2.29 109.361 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.57 55.48 3.41 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.69 -0.888 . . . . 3.17 109.927 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -84.55 112.71 20.66 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.555 0.693 . . . . 3.29 110.617 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.6 p -97.78 151.92 19.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 2.15 109.939 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 94' ' ' ALA . 72.1 t -68.37 132.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 1.45 109.984 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 97' ' ' VAL . 74.7 t -129.31 137.76 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.615 -0.678 . . . . 1.51 109.987 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.25 95.48 5.67 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.375 -0.828 . . . . 1.34 109.184 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -56.94 -41.14 77.72 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.508 -0.745 . . . . 2.82 111.543 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HA ' HD12 ' A' ' 121' ' ' LEU . 13.8 mt-30 -110.38 177.69 4.62 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.421 -0.799 . . . . 3.31 110.565 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.489 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.9 tt -84.89 129.07 34.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.566 -0.709 . . . . 2.45 110.596 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 mt -120.61 128.73 25.65 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.192 -0.67 . . . . 2.66 109.192 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.13 157.58 53.84 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.558 1.293 . . . . 1.99 111.258 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.526 HG13 ' HA ' ' A' ' 118' ' ' ALA . 4.9 mt -54.15 146.68 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.824 -0.547 . . . . 2.53 110.436 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' VAL . 1.5 m-80 53.39 71.34 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.513 0.673 . . . . 3.11 111.163 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.8 m -144.52 121.57 11.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.594 -0.691 . . . . 1.96 109.345 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.57 91.94 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.729 -0.607 . . . . 2.17 110.274 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 142.83 26.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.534 -0.729 . . . . 1.54 110.029 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.506 HG23 ' CA ' ' A' ' 112' ' ' GLY . 73.3 p -118.97 -169.92 1.82 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.536 -0.727 . . . . 2.04 110.67 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.15 -23.05 44.69 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.776 -0.578 . . . . 2.3 111.805 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.05 -54.08 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.166 -0.959 . . . . 2.89 110.074 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.1 mtm -85.16 -21.35 29.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 2.29 110.879 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 3.7 mtt -86.39 126.13 34.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.242 -0.911 . . . . 3.87 110.743 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -121.16 100.89 7.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 2.76 109.817 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.509 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -79.95 94.51 5.9 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.397 -0.814 . . . . 1.63 110.525 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.86 164.69 18.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.601 -0.687 . . . . 2.9 110.09 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -73.43 99.29 2.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.737 . . . . 3.47 110.461 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.441 HG12 HG22 ' A' ' 76' ' ' VAL . 8.2 p -146.31 160.87 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 2.41 110.362 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.4 p -109.23 151.11 41.86 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 2.86 110.398 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.83 175.02 46.56 Favored 'Cis proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.868 -2.138 . . . . 2.1 110.766 -0.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 92.9 7.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.421 -0.8 . . . . 4.21 109.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.76 -95.06 0.34 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.574 -1.41 . . . . 1.45 109.574 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.592 ' HB ' ' HG ' ' A' ' 125' ' ' LEU . 36.0 mt -109.0 126.98 28.13 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.949 . . . . 1.55 109.679 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.43 173.13 13.67 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.919 1.483 . . . . 1.58 110.757 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.9 p -95.24 37.25 1.18 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 2.39 110.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 11.0 pt-20 -85.1 -36.49 21.11 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.196 -0.94 . . . . 2.69 110.326 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -107.89 11.26 28.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.422 -0.799 . . . . 2.65 110.57 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.3 tp -60.49 -34.93 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.35 -0.844 . . . . 2.18 110.606 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.433 ' HA ' HG22 ' A' ' 111' ' ' VAL . 10.9 t -59.05 -35.48 73.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 2.49 110.327 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -82.92 -25.72 32.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.503 -0.748 . . . . 3.71 110.518 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.433 ' HB3' ' HE1' ' A' ' 113' ' ' MET . 15.3 mt -99.63 8.25 44.54 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.824 . . . . 1.83 111.362 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 108' ' ' SER . 12.6 t -57.99 124.24 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 120.967 -1.083 . . . . 2.0 110.122 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.506 ' CA ' HG23 ' A' ' 88' ' ' THR . . . 79.6 28.64 51.14 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.097 -1.201 . . . . 1.64 110.097 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.433 ' HE1' ' HB3' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -84.89 147.51 26.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.447 -1.031 . . . . 2.89 110.194 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -87.5 125.3 34.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 2.89 110.043 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 84' ' ' ASN . 11.2 p -79.51 153.5 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.601 -0.687 . . . . 1.83 110.181 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.9 -6.04 27.37 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.228 -0.92 . . . . 3.35 110.789 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 1.7 mmt85 -124.7 169.76 11.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.411 -0.806 . . . . 4.82 109.738 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.526 ' HA ' HG13 ' A' ' 83' ' ' ILE . . . -80.29 137.21 36.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 2.03 110.359 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.543 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 53.3 t -110.45 138.9 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.652 . . . . 1.75 110.233 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.489 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 97.6 m-85 -101.05 -159.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.569 -0.707 . . . . 3.37 110.332 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -65.84 -153.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.571 -0.706 . . . . 1.91 110.687 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.436 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -45.74 84.3 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.609 0 CA-C-O 121.539 0.685 . . . . 2.37 112.453 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' LEU . 34.7 tt0 -120.3 147.35 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.722 -0.611 . . . . 2.52 109.513 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 96.0 m -76.29 133.9 39.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 1.85 110.116 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.592 ' HG ' ' HB ' ' A' ' 102' ' ' ILE . 1.5 tp -75.24 133.04 41.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.565 -0.709 . . . . 1.48 109.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.94 154.86 67.78 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.64 -0.663 . . . . 3.04 110.452 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -70.69 -26.64 22.98 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.926 1.488 . . . . 2.06 110.886 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.73 -28.51 64.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.479 -0.763 . . . . 2.98 110.544 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.4 ttm -80.03 -40.33 28.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.387 -0.821 . . . . 3.79 110.251 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.428 HG12 ' HE2' ' A' ' 113' ' ' MET . 94.3 t -90.03 113.75 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.497 -0.752 . . . . 2.22 109.85 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -82.52 -15.27 52.99 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.542 -0.724 . . . . 5.2 111.148 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -102.64 28.43 6.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.188 -0.945 . . . . 4.84 110.605 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -79.8 151.15 30.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.231 -0.918 . . . . 3.48 110.17 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.847 -1.073 . . . . 2.94 110.357 -179.682 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.3 t30 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 120.863 0.363 . . . . 4.3899999999999997 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -88.66 -179.41 6.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.424 -0.798 . . . . 3.9500000000000002 110.413 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.98 133.64 37.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 1.97 110.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -100.24 155.25 17.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 1.9099999999999999 109.978 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' HG2' ' A' ' 22' ' ' MET . 52.2 t -79.34 101.25 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.458 -0.776 . . . . 1.1200000000000001 109.949 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' A' ' 27' ' ' VAL . 15.8 t -116.94 123.48 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.443 -0.786 . . . . 1.1000000000000001 109.47 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -61.17 132.56 54.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.558 -0.714 . . . . 1.0 109.977 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -82.63 -45.77 14.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 2.4199999999999999 110.228 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -92.95 179.32 5.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.495 -0.753 . . . . 2.02 110.719 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -90.27 133.56 34.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.636 -0.665 . . . . 2.1299999999999999 109.597 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.699 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 47.9 mm -110.5 142.36 25.9 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 2.0499999999999998 110.333 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.45 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 42.6 Cg_endo -78.44 -164.71 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.705 1.371 . . . . 1.96 110.358 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.68 144.68 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.18 -0.95 . . . . 2.6299999999999999 110.601 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.8 m120 50.09 66.48 1.13 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.367 0.603 . . . . 2.9300000000000002 110.54 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 19.8 m -135.34 127.26 29.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.473 -0.767 . . . . 1.7 110.695 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.72 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -70.08 124.99 25.47 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.567 -0.708 . . . . 1.6299999999999999 109.764 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.578 HD21 HG13 ' A' ' 11' ' ' ILE . 42.0 mt -71.97 156.46 39.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.484 -0.76 . . . . 1.27 110.992 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -120.22 178.94 4.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.422 -0.799 . . . . 1.6200000000000001 110.033 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.97 -42.18 94.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.445 -0.784 . . . . 2.3500000000000001 110.419 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.11 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.723 . . . . 1.8999999999999999 110.135 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 55.1 mtt -74.35 -31.81 62.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.549 -0.719 . . . . 1.8899999999999999 110.57 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.597 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.4 ttt -86.17 112.49 21.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.381 -0.825 . . . . 2.9900000000000002 110.509 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -111.42 129.42 56.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.597 -0.689 . . . . 2.1400000000000001 110.226 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.7 76.7 7.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.461 -0.775 . . . . 1.4299999999999999 110.139 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -103.55 146.82 27.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.787 . . . . 2.2599999999999998 110.422 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 3' ' ' ALA . 61.3 t -85.39 84.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.502 -0.749 . . . . 2.1099999999999999 109.449 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.2 m -140.55 163.18 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.402 -0.811 . . . . 1.9099999999999999 110.783 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 19.9 p -99.53 163.22 18.96 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.599 -0.688 . . . . 2.8799999999999999 110.269 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -75.83 151.68 95.98 Favored 'Cis proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.91 -2.121 . . . . 2.3599999999999999 110.835 -0.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.95 89.39 1.41 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.557 0.694 . . . . 3.3999999999999999 110.593 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 -101.95 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.119 -1.592 . . . . 1.73 109.119 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 1.006 HD12 HD12 ' A' ' 55' ' ' LEU . 15.6 mt -110.57 131.03 22.28 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.586 -0.949 . . . . 1.46 109.546 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.79 -177.27 2.44 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 124.017 1.535 . . . . 1.8999999999999999 111.266 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.91 23.71 4.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.496 -0.752 . . . . 1.8899999999999999 111.321 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -66.95 -50.19 63.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.124 -0.985 . . . . 3.3300000000000001 109.747 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 2.9 mm-40 -96.01 46.01 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 3.4199999999999999 109.794 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -53.19 -46.76 97.64 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.594 -0.691 . . . . 1.8899999999999999 111.322 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.1 Cg_endo -67.96 -28.32 35.68 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.176 1.092 . . . . 2.3700000000000001 111.237 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 6.1 m-80 -82.47 -42.37 18.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.304 -0.873 . . . . 2.7000000000000002 110.154 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.648 HD21 HG21 ' A' ' 32' ' ' ILE . 5.5 mp -71.3 -34.46 70.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 2.6800000000000002 111.232 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.04 144.95 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.336 -0.853 . . . . 1.7 111.04 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.72 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 71.77 13.33 75.11 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.043 -0.823 . . . . 1.51 111.043 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.468 ' CE ' ' HG ' ' A' ' 40' ' ' LEU . 7.4 ptp -74.66 150.92 39.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.912 -1.346 . . . . 2.9100000000000001 109.514 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.02 130.0 46.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.583 -0.698 . . . . 2.9900000000000002 110.207 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 30.7 m -85.65 159.59 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.64 -0.662 . . . . 1.3999999999999999 110.374 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.88 -17.66 32.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.742 . . . . 2.1299999999999999 111.071 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.82 -172.96 4.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.269 -0.895 . . . . 3.7400000000000002 110.465 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.11 134.13 40.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 2.0099999999999998 110.216 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 73.4 t -105.93 126.56 30.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.664 . . . . 1.5800000000000001 109.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.738 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.0 Cg_endo -71.17 -172.88 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.771 1.406 . . . . 1.9099999999999999 110.968 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.63 140.31 33.25 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 2.02 111.013 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.82 35.31 79.43 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 110.784 -0.926 . . . . 1.3600000000000001 110.784 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.597 HG21 HG13 ' A' ' 49' ' ' VAL . 93.5 m -88.39 124.86 34.36 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.304 -1.115 . . . . 1.3400000000000001 110.355 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.0 t -70.47 160.33 32.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.491 -0.756 . . . . 1.26 110.105 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.006 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.76 107.56 4.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.407 -0.808 . . . . 1.2 109.906 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.3 mtt -103.31 131.83 21.71 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.536 -0.728 . . . . 2.5299999999999998 110.319 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.09 -27.68 19.96 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.95 1.5 . . . . 1.45 110.826 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.91 -29.78 63.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.389 -0.819 . . . . 2.8399999999999999 110.597 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.4 mtt -82.36 -30.78 30.11 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.361 -0.837 . . . . 2.3700000000000001 110.801 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG11 ' HB3' ' A' ' 63' ' ' TYR . 78.0 t -101.77 136.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.248 -0.907 . . . . 1.1799999999999999 110.358 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HE3' ' HG3' ' A' ' 123' ' ' GLN . 14.3 mmtt -71.27 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.444 -0.785 . . . . 3.6400000000000001 109.515 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.06 85.11 5.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.932 -1.105 . . . . 3.8799999999999999 109.629 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.566 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -74.64 -40.33 61.56 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.455 -0.778 . . . . 2.2000000000000002 110.885 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -169.78 -177.22 2.6 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 4.1699999999999999 110.804 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.45 62.31 7.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 3.9399999999999999 109.911 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.18 -30.1 65.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.934 -1.266 . . . . 2.46 109.934 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 p -73.79 140.92 46.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 2.5899999999999999 110.279 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.7 p -90.05 -68.52 0.78 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.56 -0.712 . . . . 4.3499999999999996 110.354 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -84.92 138.1 37.5 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.456 -0.778 . . . . 2.9100000000000001 110.139 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 49.1 Cg_endo -73.42 -98.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.811 1.427 . . . . 2.3799999999999999 110.315 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 -81.86 0.91 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.361 -1.495 . . . . 2.1800000000000002 109.361 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.57 55.48 3.41 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.69 -0.888 . . . . 2.7000000000000002 109.927 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -84.55 112.71 20.66 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.555 0.693 . . . . 2.9100000000000001 110.617 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.6 p -97.78 151.92 19.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 1.8400000000000001 109.939 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.591 ' HB ' HD23 ' A' ' 125' ' ' LEU . 72.1 t -68.37 132.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 0.85999999999999999 109.984 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.724 HG21 HG11 ' A' ' 97' ' ' VAL . 74.7 t -129.31 137.76 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.615 -0.678 . . . . 0.97999999999999998 109.987 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.25 95.48 5.67 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.375 -0.828 . . . . 0.92000000000000004 109.184 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -56.94 -41.14 77.72 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.508 -0.745 . . . . 2.4100000000000001 111.543 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HA ' HD13 ' A' ' 121' ' ' LEU . 13.8 mt-30 -110.38 177.69 4.62 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.421 -0.799 . . . . 2.7999999999999998 110.565 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.9 tt -84.89 129.07 34.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.566 -0.709 . . . . 1.8999999999999999 110.596 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 mt -120.61 128.73 25.65 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.192 -0.67 . . . . 2.1400000000000001 109.192 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.13 157.58 53.84 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.558 1.293 . . . . 1.8700000000000001 111.258 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.546 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 4.9 mt -54.15 146.68 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.824 -0.547 . . . . 2.1800000000000002 110.436 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 2.2 m120 53.39 71.34 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.513 0.673 . . . . 2.6899999999999999 111.163 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.8 m -144.52 121.57 11.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.594 -0.691 . . . . 1.6499999999999999 109.345 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.57 91.94 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.729 -0.607 . . . . 1.78 110.274 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 142.83 26.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.534 -0.729 . . . . 1.3100000000000001 110.029 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.605 HG22 ' CA ' ' A' ' 112' ' ' GLY . 73.3 p -118.97 -169.92 1.82 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.536 -0.727 . . . . 1.74 110.67 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.552 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -57.15 -23.05 44.69 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.776 -0.578 . . . . 1.8700000000000001 111.805 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.05 -54.08 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.166 -0.959 . . . . 2.2999999999999998 110.074 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.1 mtm -85.16 -21.35 29.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 1.8999999999999999 110.879 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . 0.669 ' SD ' HD11 ' A' ' 107' ' ' ILE . 3.7 mtt -86.39 126.13 34.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.242 -0.911 . . . . 3.3999999999999999 110.743 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -121.16 100.89 7.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 2.3700000000000001 109.817 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -79.95 94.51 5.9 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.397 -0.814 . . . . 1.3300000000000001 110.525 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.86 164.69 18.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.601 -0.687 . . . . 2.8999999999999999 110.09 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -73.43 99.29 2.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.737 . . . . 3.4700000000000002 110.461 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 76' ' ' VAL . 8.2 p -146.31 160.87 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 1.97 110.362 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.4 p -109.23 151.11 41.86 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 2.52 110.398 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.604 ' O ' HG21 ' A' ' 124' ' ' THR . 52.7 Cg_endo -79.83 175.02 46.56 Favored 'Cis proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.868 -2.138 . . . . 1.9399999999999999 110.766 -0.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 92.9 7.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.421 -0.8 . . . . 3.8900000000000001 109.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.76 -95.06 0.34 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.574 -1.41 . . . . 1.3799999999999999 109.574 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 125' ' ' LEU . 36.0 mt -109.0 126.98 28.13 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.949 . . . . 1.0600000000000001 109.679 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.43 173.13 13.67 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.919 1.483 . . . . 1.4099999999999999 110.757 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.9 p -95.24 37.25 1.18 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 2.0 110.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 11.0 pt-20 -85.1 -36.49 21.11 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.196 -0.94 . . . . 2.6899999999999999 110.326 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -107.89 11.26 28.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.422 -0.799 . . . . 2.6499999999999999 110.57 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.8 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.3 tp -60.49 -34.93 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.35 -0.844 . . . . 1.6699999999999999 110.606 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.9 t -59.05 -35.48 73.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 2.2000000000000002 110.327 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -82.92 -25.72 32.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.503 -0.748 . . . . 3.3500000000000001 110.518 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 15.3 mt -99.63 8.25 44.54 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.824 . . . . 1.28 111.362 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 107' ' ' ILE . 12.6 t -57.99 124.24 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 120.967 -1.083 . . . . 1.6599999999999999 110.122 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 79.6 28.64 51.14 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.097 -1.201 . . . . 1.5800000000000001 110.097 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.468 ' HE2' ' HB3' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -84.89 147.51 26.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.447 -1.031 . . . . 2.46 110.194 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -87.5 125.3 34.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 2.5299999999999998 110.043 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 117' ' ' ARG . 11.2 p -79.51 153.5 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.601 -0.687 . . . . 1.5 110.181 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.9 -6.04 27.37 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.228 -0.92 . . . . 2.8900000000000001 110.789 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.7 mmt85 -124.7 169.76 11.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.411 -0.806 . . . . 4.2300000000000004 109.738 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.546 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -80.29 137.21 36.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 1.6699999999999999 110.359 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 53.3 t -110.45 138.9 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.652 . . . . 1.3500000000000001 110.233 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.534 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 97.6 m-85 -101.05 -159.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.569 -0.707 . . . . 3.1600000000000001 110.332 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -65.84 -153.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.571 -0.706 . . . . 1.54 110.687 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -45.74 84.3 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.609 0 CA-C-O 121.539 0.685 . . . . 2.3700000000000001 112.453 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.501 ' HG3' ' HE3' ' A' ' 61' ' ' LYS . 34.7 tt0 -120.3 147.35 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.722 -0.611 . . . . 2.1899999999999999 109.513 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.604 HG21 ' O ' ' A' ' 99' ' ' PRO . 96.0 m -76.29 133.9 39.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 1.45 110.116 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 102' ' ' ILE . 1.5 tp -75.24 133.04 41.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.565 -0.709 . . . . 0.98999999999999999 109.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.49 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.94 154.86 67.78 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.64 -0.663 . . . . 2.5 110.452 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HA ' HD11 ' A' ' 102' ' ' ILE . 44.4 Cg_endo -70.69 -26.64 22.98 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.926 1.488 . . . . 1.8600000000000001 110.886 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.73 -28.51 64.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.479 -0.763 . . . . 2.98 110.544 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.4 ttm -80.03 -40.33 28.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.387 -0.821 . . . . 3.4500000000000002 110.251 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.3 t -90.03 113.75 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.497 -0.752 . . . . 1.8700000000000001 109.85 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -82.52 -15.27 52.99 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.542 -0.724 . . . . 4.7699999999999996 111.148 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -102.64 28.43 6.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.188 -0.945 . . . . 4.3300000000000001 110.605 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -79.8 151.15 30.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.231 -0.918 . . . . 3.0899999999999999 110.17 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.847 -1.073 . . . . 2.9399999999999999 110.357 -179.682 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 61.3 t30 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 120.863 0.363 . . . . 4.3899999999999997 110.33 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -88.66 -179.41 6.02 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.424 -0.798 . . . . 3.9500000000000002 110.413 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.486 ' HA ' HG22 ' A' ' 26' ' ' VAL . . . -77.98 133.64 37.97 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 1.97 110.449 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.0 t -100.24 155.25 17.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.751 -0.593 . . . . 1.9099999999999999 109.978 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.597 HG13 ' HG2' ' A' ' 22' ' ' MET . 52.2 t -79.34 101.25 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.458 -0.776 . . . . 1.1200000000000001 109.949 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.547 HG21 ' CG2' ' A' ' 27' ' ' VAL . 15.8 t -116.94 123.48 71.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.443 -0.786 . . . . 1.1000000000000001 109.47 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 21' ' ' MET . . . -61.17 132.56 54.08 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.558 -0.714 . . . . 1.0 109.977 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -82.63 -45.77 14.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.521 -0.737 . . . . 2.4199999999999999 110.228 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -92.95 179.32 5.49 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.495 -0.753 . . . . 2.02 110.719 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -90.27 133.56 34.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.636 -0.665 . . . . 2.1299999999999999 109.597 179.289 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.699 ' HB ' ' HB ' ' A' ' 49' ' ' VAL . 47.9 mm -110.5 142.36 25.9 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.535 -0.728 . . . . 2.0499999999999998 110.333 -179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.45 ' HG2' ' OG1' ' A' ' 15' ' ' THR . 42.6 Cg_endo -78.44 -164.71 0.29 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 O-C-N 123.705 1.371 . . . . 1.96 110.358 178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mt -87.68 144.68 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 121.18 -0.95 . . . . 2.6299999999999999 110.601 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 50.09 66.48 1.13 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.367 0.603 . . . . 2.9300000000000002 110.54 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 12' ' ' PRO . 19.8 m -135.34 127.26 29.49 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.473 -0.767 . . . . 1.7 110.695 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.72 ' HB1' ' HA2' ' A' ' 42' ' ' GLY . . . -70.08 124.99 25.47 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.567 -0.708 . . . . 1.6299999999999999 109.764 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.578 HD21 HG13 ' A' ' 11' ' ' ILE . 42.0 mt -71.97 156.46 39.22 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.484 -0.76 . . . . 1.27 110.992 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -120.22 178.94 4.45 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.422 -0.799 . . . . 1.6200000000000001 110.033 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mt -64.97 -42.18 94.8 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.445 -0.784 . . . . 2.3500000000000001 110.419 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.5 mp -65.11 -38.3 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.544 -0.723 . . . . 1.8999999999999999 110.135 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' ALA . 55.1 mtt -74.35 -31.81 62.56 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.549 -0.719 . . . . 1.8899999999999999 110.57 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.597 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.4 ttt -86.17 112.49 21.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.381 -0.825 . . . . 2.9900000000000002 110.509 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.1 mttt -111.42 129.42 56.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.597 -0.689 . . . . 2.1400000000000001 110.226 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.7 76.7 7.23 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.461 -0.775 . . . . 1.4299999999999999 110.139 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -103.55 146.82 27.97 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.442 -0.787 . . . . 2.2599999999999998 110.422 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 3' ' ' ALA . 61.3 t -85.39 84.31 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.502 -0.749 . . . . 2.1099999999999999 109.449 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 6' ' ' VAL . 16.2 m -140.55 163.18 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.402 -0.811 . . . . 1.9099999999999999 110.783 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 29' ' ' PRO . 19.9 p -99.53 163.22 18.96 Favored Pre-proline 0 N--CA 1.499 2.019 0 O-C-N 121.599 -0.688 . . . . 2.8799999999999999 110.269 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 28' ' ' THR . 49.8 Cg_endo -75.83 151.68 95.98 Favored 'Cis proline' 0 N--CA 1.49 1.276 0 C-N-CA 121.91 -2.121 . . . . 2.3599999999999999 110.835 -0.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.95 89.39 1.41 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 121.557 0.694 . . . . 3.3999999999999999 110.593 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.7 -101.95 0.39 Allowed Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.119 -1.592 . . . . 1.73 109.119 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 1.006 HD12 HD12 ' A' ' 55' ' ' LEU . 15.6 mt -110.57 131.03 22.28 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.586 -0.949 . . . . 1.46 109.546 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.79 -177.27 2.44 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 O-C-N 124.017 1.535 . . . . 1.8999999999999999 111.266 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.91 23.71 4.06 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.496 -0.752 . . . . 1.8899999999999999 111.321 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -66.95 -50.19 63.1 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.124 -0.985 . . . . 3.3300000000000001 109.747 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.478 ' HB3' ' HB2' ' A' ' 39' ' ' ASN . 2.9 mm-40 -96.01 46.01 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.709 -0.619 . . . . 3.4199999999999999 109.794 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -53.19 -46.76 97.64 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.594 -0.691 . . . . 1.8899999999999999 111.322 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 37' ' ' ILE . 42.1 Cg_endo -67.96 -28.32 35.68 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 O-C-N 123.176 1.092 . . . . 2.3700000000000001 111.237 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.478 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . 6.1 m-80 -82.47 -42.37 18.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.304 -0.873 . . . . 2.7000000000000002 110.154 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.648 HD21 HG21 ' A' ' 32' ' ' ILE . 5.5 mp -71.3 -34.46 70.65 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.553 -0.717 . . . . 2.6800000000000002 111.232 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -55.04 144.95 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.336 -0.853 . . . . 1.7 111.04 -179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.72 ' HA2' ' HB1' ' A' ' 16' ' ' ALA . . . 71.77 13.33 75.11 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 111.043 -0.823 . . . . 1.51 111.043 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.468 ' CE ' ' HG ' ' A' ' 40' ' ' LEU . 7.4 ptp -74.66 150.92 39.37 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.912 -1.346 . . . . 2.9100000000000001 109.514 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -100.02 130.0 46.14 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.583 -0.698 . . . . 2.9900000000000002 110.207 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 45' ' ' VAL . 30.7 m -85.65 159.59 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.64 -0.662 . . . . 1.3999999999999999 110.374 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -86.88 -17.66 32.76 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.513 -0.742 . . . . 2.1299999999999999 111.071 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.82 -172.96 4.1 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.269 -0.895 . . . . 3.7400000000000002 110.465 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.11 134.13 40.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.404 -0.81 . . . . 2.0099999999999998 110.216 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.699 ' HB ' ' HB ' ' A' ' 11' ' ' ILE . 73.4 t -105.93 126.56 30.36 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.637 -0.664 . . . . 1.5800000000000001 109.864 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.738 ' HA ' HD12 ' A' ' 10' ' ' LEU . 43.0 Cg_endo -71.17 -172.88 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.266 0 O-C-N 123.771 1.406 . . . . 1.9099999999999999 110.968 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.63 140.31 33.25 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.307 -0.871 . . . . 2.02 111.013 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.82 35.31 79.43 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 110.784 -0.926 . . . . 1.3600000000000001 110.784 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.597 HG21 HG13 ' A' ' 49' ' ' VAL . 93.5 m -88.39 124.86 34.36 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.304 -1.115 . . . . 1.3400000000000001 110.355 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 11.0 t -70.47 160.33 32.6 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.491 -0.756 . . . . 1.26 110.105 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.006 HD12 HD12 ' A' ' 32' ' ' ILE . 0.1 OUTLIER -71.76 107.56 4.63 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.407 -0.808 . . . . 1.2 109.906 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 11.3 mtt -103.31 131.83 21.71 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.536 -0.728 . . . . 2.5299999999999998 110.319 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.09 -27.68 19.96 Favored 'Trans proline' 0 N--CA 1.488 1.156 0 O-C-N 123.95 1.5 . . . . 1.45 110.826 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -72.91 -29.78 63.4 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.389 -0.819 . . . . 2.8399999999999999 110.597 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.4 mtt -82.36 -30.78 30.11 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.361 -0.837 . . . . 2.3700000000000001 110.801 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 HG11 ' HB3' ' A' ' 63' ' ' TYR . 78.0 t -101.77 136.61 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.248 -0.907 . . . . 1.1799999999999999 110.358 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HE3' ' HG3' ' A' ' 123' ' ' GLN . 14.3 mmtt -71.27 -97.73 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.444 -0.785 . . . . 3.6400000000000001 109.515 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.06 85.11 5.41 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.932 -1.105 . . . . 3.8799999999999999 109.629 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.566 ' HB3' HG11 ' A' ' 60' ' ' VAL . 1.0 OUTLIER -74.64 -40.33 61.56 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.455 -0.778 . . . . 2.2000000000000002 110.885 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' HB3' HD12 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -169.78 -177.22 2.6 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.28 -0.887 . . . . 4.1699999999999999 110.804 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -87.45 62.31 7.07 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.621 -0.674 . . . . 3.9399999999999999 109.911 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -72.18 -30.1 65.63 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.934 -1.266 . . . . 2.46 109.934 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.5 p -73.79 140.92 46.2 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.468 -1.019 . . . . 2.5899999999999999 110.279 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.7 p -90.05 -68.52 0.78 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.56 -0.712 . . . . 4.3499999999999996 110.354 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.2 m -84.92 138.1 37.5 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.456 -0.778 . . . . 2.9100000000000001 110.139 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 96' ' ' GLU . 49.1 Cg_endo -73.42 -98.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.317 -1.115 0 O-C-N 123.811 1.427 . . . . 2.3799999999999999 110.315 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.18 -81.86 0.91 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.361 -1.495 . . . . 2.1800000000000002 109.361 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.57 55.48 3.41 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.69 -0.888 . . . . 2.7000000000000002 109.927 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 96' ' ' GLU . 0.3 OUTLIER -84.55 112.71 20.66 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.555 0.693 . . . . 2.9100000000000001 110.617 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.6 p -97.78 151.92 19.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.489 -0.757 . . . . 1.8400000000000001 109.939 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.591 ' HB ' HD23 ' A' ' 125' ' ' LEU . 72.1 t -68.37 132.71 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.491 -0.756 . . . . 0.85999999999999999 109.984 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.724 HG21 HG11 ' A' ' 97' ' ' VAL . 74.7 t -129.31 137.76 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.615 -0.678 . . . . 0.97999999999999998 109.987 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 122' ' ' ASP . . . -79.25 95.48 5.67 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.375 -0.828 . . . . 0.92000000000000004 109.184 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -56.94 -41.14 77.72 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.508 -0.745 . . . . 2.4100000000000001 111.543 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.47 ' HA ' HD13 ' A' ' 121' ' ' LEU . 13.8 mt-30 -110.38 177.69 4.62 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.421 -0.799 . . . . 2.7999999999999998 110.565 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 120' ' ' TYR . 1.9 tt -84.89 129.07 34.87 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.566 -0.709 . . . . 1.8999999999999999 110.596 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' HB ' ' HB ' ' A' ' 119' ' ' VAL . 24.8 mt -120.61 128.73 25.65 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 109.192 -0.67 . . . . 2.1400000000000001 109.192 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.13 157.58 53.84 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.558 1.293 . . . . 1.8700000000000001 111.258 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.546 ' CG1' ' HB2' ' A' ' 118' ' ' ALA . 4.9 mt -54.15 146.68 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.309 0 O-C-N 121.824 -0.547 . . . . 2.1800000000000002 110.436 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 53.39 71.34 0.51 Allowed 'General case' 0 N--CA 1.504 2.247 0 CA-C-O 121.513 0.673 . . . . 2.6899999999999999 111.163 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 55.8 m -144.52 121.57 11.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.594 -0.691 . . . . 1.6499999999999999 109.345 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -65.57 91.94 0.13 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.729 -0.607 . . . . 1.78 110.274 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.2 142.83 26.87 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.534 -0.729 . . . . 1.3100000000000001 110.029 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.605 HG22 ' CA ' ' A' ' 112' ' ' GLY . 73.3 p -118.97 -169.92 1.82 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.536 -0.727 . . . . 1.74 110.67 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.552 HD23 ' H ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -57.15 -23.05 44.69 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.776 -0.578 . . . . 1.8700000000000001 111.805 -179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.2 t -56.05 -54.08 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.166 -0.959 . . . . 2.2999999999999998 110.074 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 22.1 mtm -85.16 -21.35 29.25 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.467 -0.771 . . . . 1.8999999999999999 110.879 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . 0.669 ' SD ' HD11 ' A' ' 107' ' ' ILE . 3.7 mtt -86.39 126.13 34.15 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.242 -0.911 . . . . 3.3999999999999999 110.743 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -121.16 100.89 7.31 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.545 -0.722 . . . . 2.3700000000000001 109.817 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . . . -79.95 94.51 5.9 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.397 -0.814 . . . . 1.3300000000000001 110.525 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.86 164.69 18.73 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.601 -0.687 . . . . 2.8999999999999999 110.09 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 73' ' ' LYS . 0.8 OUTLIER -73.43 99.29 2.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.522 -0.737 . . . . 3.4700000000000002 110.461 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.724 HG11 HG21 ' A' ' 76' ' ' VAL . 8.2 p -146.31 160.87 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.673 -0.642 . . . . 1.97 110.362 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 90.4 p -109.23 151.11 41.86 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.549 -0.719 . . . . 2.52 110.398 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.604 ' O ' HG21 ' A' ' 124' ' ' THR . 52.7 Cg_endo -79.83 175.02 46.56 Favored 'Cis proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.868 -2.138 . . . . 1.9399999999999999 110.766 -0.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 92.9 7.73 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.421 -0.8 . . . . 3.8900000000000001 109.932 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -79.76 -95.06 0.34 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 109.574 -1.41 . . . . 1.3799999999999999 109.574 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.745 HD12 HD11 ' A' ' 125' ' ' LEU . 36.0 mt -109.0 126.98 28.13 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.586 -0.949 . . . . 1.0600000000000001 109.679 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.43 173.13 13.67 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.919 1.483 . . . . 1.4099999999999999 110.757 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 77.9 p -95.24 37.25 1.18 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.417 -0.802 . . . . 2.0 110.765 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.445 ' HG3' ' N ' ' A' ' 106' ' ' GLU . 11.0 pt-20 -85.1 -36.49 21.11 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.196 -0.94 . . . . 2.6899999999999999 110.326 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.445 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -107.89 11.26 28.18 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.422 -0.799 . . . . 2.6499999999999999 110.57 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.8 ' O ' HG23 ' A' ' 111' ' ' VAL . 7.3 tp -60.49 -34.93 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 121.35 -0.844 . . . . 1.6699999999999999 110.606 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.9 t -59.05 -35.48 73.4 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.456 -0.777 . . . . 2.2000000000000002 110.327 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.3 tttt -82.92 -25.72 32.13 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.503 -0.748 . . . . 3.3500000000000001 110.518 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.468 ' HB3' ' HE2' ' A' ' 113' ' ' MET . 15.3 mt -99.63 8.25 44.54 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.381 -0.824 . . . . 1.28 111.362 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 107' ' ' ILE . 12.6 t -57.99 124.24 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 O-C-N 120.967 -1.083 . . . . 1.6599999999999999 110.122 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 88' ' ' THR . . . 79.6 28.64 51.14 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.097 -1.201 . . . . 1.5800000000000001 110.097 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.468 ' HE2' ' HB3' ' A' ' 110' ' ' LEU . 0.5 OUTLIER -84.89 147.51 26.74 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.447 -1.031 . . . . 2.46 110.194 179.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -87.5 125.3 34.23 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.473 -0.767 . . . . 2.5299999999999998 110.043 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 117' ' ' ARG . 11.2 p -79.51 153.5 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.601 -0.687 . . . . 1.5 110.181 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.9 -6.04 27.37 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.228 -0.92 . . . . 2.8900000000000001 110.789 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.663 ' H ' HG22 ' A' ' 115' ' ' VAL . 1.7 mmt85 -124.7 169.76 11.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.411 -0.806 . . . . 4.2300000000000004 109.738 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.546 ' HB2' ' CG1' ' A' ' 83' ' ' ILE . . . -80.29 137.21 36.57 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.296 -0.877 . . . . 1.6699999999999999 110.359 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 81' ' ' ILE . 53.3 t -110.45 138.9 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.657 -0.652 . . . . 1.3500000000000001 110.233 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.534 ' HA ' ' HG ' ' A' ' 80' ' ' LEU . 97.6 m-85 -101.05 -159.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.569 -0.707 . . . . 3.1600000000000001 110.332 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 123' ' ' GLN . 0.9 OUTLIER -65.84 -153.25 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.571 -0.706 . . . . 1.54 110.687 -179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' A' ' 77' ' ' ALA . 0.7 OUTLIER -45.74 84.3 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.609 0 CA-C-O 121.539 0.685 . . . . 2.3700000000000001 112.453 -178.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.501 ' HG3' ' HE3' ' A' ' 61' ' ' LYS . 34.7 tt0 -120.3 147.35 45.11 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.722 -0.611 . . . . 2.1899999999999999 109.513 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.604 HG21 ' O ' ' A' ' 99' ' ' PRO . 96.0 m -76.29 133.9 39.91 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.323 -0.861 . . . . 1.45 110.116 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.745 HD11 HD12 ' A' ' 102' ' ' ILE . 1.5 tp -75.24 133.04 41.46 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.565 -0.709 . . . . 0.98999999999999999 109.424 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.49 ' N ' HD12 ' A' ' 125' ' ' LEU . 0.0 OUTLIER -123.94 154.86 67.78 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.64 -0.663 . . . . 2.5 110.452 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.492 ' HA ' HD11 ' A' ' 102' ' ' ILE . 44.4 Cg_endo -70.69 -26.64 22.98 Favored 'Trans proline' 0 N--CA 1.49 1.281 0 O-C-N 123.926 1.488 . . . . 1.8600000000000001 110.886 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.73 -28.51 64.77 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.479 -0.763 . . . . 2.98 110.544 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 30.4 ttm -80.03 -40.33 28.0 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.387 -0.821 . . . . 3.4500000000000002 110.251 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.3 t -90.03 113.75 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.497 -0.752 . . . . 1.8700000000000001 109.85 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -82.52 -15.27 52.99 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.542 -0.724 . . . . 4.7699999999999996 111.148 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -102.64 28.43 6.07 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.188 -0.945 . . . . 4.3300000000000001 110.605 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -79.8 151.15 30.47 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.231 -0.918 . . . . 3.0899999999999999 110.17 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 117.847 -1.073 . . . . 2.9399999999999999 110.357 -179.682 . . . . . . . . 0 0 . 1 stop_ save_